Category: CAR T-cell Therapy

CAR T-cell Therapy in 2022: What You Need to Know Part II

Rayne H. Rouce, MD, BS, Texas Children’s Cancer Center for Cell and Gene Therapy, Houston, TX

CAR T-cell Therapy in 2022: What You Need to Know

Caron Jacobson, MD, Dana-Farber Cancer Institute, Boston, MA

Highpoints from Attending the 2021 American Society of Hematology Conference

Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY

CAR T-cell Therapy: The Nurse’s Role in Treating Patients

Elizabeth A. Weber, BSN, RN, Heather DiFilippo, MSN, CRNP and Erin Medoff, RN, MSN, APRN

A Discussion on the Future of CAR T-cell Therapy with Dr. Frederick Locke

Frederick L. Locke, MD, Moffitt Cancer Center, Tampa, FL

CAR T-cell Therapy: A Deeper Dive into Adverse Effects and Financial Toxicities

Sergio Giralt, MD, Memorial Sloan Kettering Cancer Center and Gunjan Shah, MD, Memorial Sloan Kettering Cancer Center
Scroll to Top